Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging.

MLA

Becker, Guillaume, et al. “Preclinical Evaluation of [18F]2FNQ1P as the First Fluorinated Serotonin 5-HT6 Radioligand for PET Imaging.” European Journal of Nuclear Medicine and Molecular Imaging, vol. 42, no. 3, Mar. 2015, pp. 495–502. EBSCOhost, https://doi.org/10.1007/s00259-014-2936-y.

APA

Becker, G., Colomb, J., Sgambato-Faure, V., Tremblay, L., Billard, T., & Zimmer, L. (2015). Preclinical evaluation of [18F]2FNQ1P as the first fluorinated serotonin 5-HT6 radioligand for PET imaging. European Journal of Nuclear Medicine and Molecular Imaging, 42(3), 495–502. https://doi.org/10.1007/s00259-014-2936-y

Chicago

Becker, Guillaume, Julie Colomb, Véronique Sgambato-Faure, Léon Tremblay, Thierry Billard, and Luc Zimmer. 2015. “Preclinical Evaluation of [18F]2FNQ1P as the First Fluorinated Serotonin 5-HT6 Radioligand for PET Imaging.” European Journal of Nuclear Medicine and Molecular Imaging 42 (3): 495–502. doi:10.1007/s00259-014-2936-y.